AU2003291896A1 - Saponins and sapogenins for use in combination therapy for cancer - Google Patents

Saponins and sapogenins for use in combination therapy for cancer

Info

Publication number
AU2003291896A1
AU2003291896A1 AU2003291896A AU2003291896A AU2003291896A1 AU 2003291896 A1 AU2003291896 A1 AU 2003291896A1 AU 2003291896 A AU2003291896 A AU 2003291896A AU 2003291896 A AU2003291896 A AU 2003291896A AU 2003291896 A1 AU2003291896 A1 AU 2003291896A1
Authority
AU
Australia
Prior art keywords
sapogenins
saponins
cancer
combination therapy
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003291896A
Inventor
Dong Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panagin Pharmaceuticals Inc
Original Assignee
Panagin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panagin Pharmaceuticals Inc filed Critical Panagin Pharmaceuticals Inc
Publication of AU2003291896A1 publication Critical patent/AU2003291896A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003291896A 2002-12-23 2003-12-23 Saponins and sapogenins for use in combination therapy for cancer Abandoned AU2003291896A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43530502P 2002-12-23 2002-12-23
US60/435,305 2002-12-23
PCT/CA2003/001938 WO2004056379A1 (en) 2002-12-23 2003-12-23 Saponins and sapogenins for use in combination therapy for cancer

Publications (1)

Publication Number Publication Date
AU2003291896A1 true AU2003291896A1 (en) 2004-07-14

Family

ID=32682215

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003291896A Abandoned AU2003291896A1 (en) 2002-12-23 2003-12-23 Saponins and sapogenins for use in combination therapy for cancer

Country Status (2)

Country Link
AU (1) AU2003291896A1 (en)
WO (1) WO2004056379A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014178802A1 (en) * 2013-04-29 2014-11-06 Alkoçlar Redal Can A protopanaxtriol composition for the treatment of prostate cancer and benign prostatic hyperplasia
KR101733665B1 (en) 2015-05-06 2017-05-10 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 Pharmaceutical composition for preventing or treating gleevec resistant leukemia comprising ginsenoside Rg3 or F1 as active ingredient
CN113082039B (en) * 2021-03-30 2023-01-13 香港浸会大学深圳研究院 Composition for treating sorafenib drug-resistant tumor and application thereof
EP4101438A1 (en) * 2021-06-11 2022-12-14 RainCastle bio. Limited Combination treatment of a saponin agent and an anthelminitic agent against cancer
WO2024046246A1 (en) * 2022-08-29 2024-03-07 石药集团中奇制药技术（石家庄）有限公司 Use of mitoxantrone liposome in combination with capecitabine in treating nasopharyngeal carcinoma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58131999A (en) * 1982-01-30 1983-08-06 Osaka Chem Lab Antitumor agent
JP3160313B2 (en) * 1991-07-01 2001-04-25 勲 北川 Anticancer drug
CN1128147A (en) * 1994-03-28 1996-08-07 广东医学院 Extract for treating tumour and its preparation and producing method
WO2001082908A2 (en) * 2000-05-01 2001-11-08 The University Of British Columbia Ginsenoside chemotherapy
CA2307393A1 (en) * 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy

Also Published As

Publication number Publication date
WO2004056379A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
AU2003284242A1 (en) Methods and compositions for use in treating cancer
AU2003302892A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2003213144A1 (en) Alkylating agent combinations in the treatment of cancer
AU2003293376A1 (en) Anti-angiogenic compounds and their use in cancer treatment
AUPS054702A0 (en) Cancer therapy
AU2003217304A1 (en) Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2003235470A1 (en) Predictive markers in cancer therapy
AU2003215460A1 (en) Cancer associated protein kinases and their uses
TWI349551B (en) Thiophenepyrimidinone derivatives and their use in therapy
EP1587837A3 (en) Prostate cancer diagnosis and treatment
IL182652A0 (en) Nitrobenzindoles and their use in cancer therapy
AU2003258061A1 (en) Therapeutic inhibitionof protein kinases in cancer cells
AU1190901A (en) Replication selective adenoviruses for use in cancer therapy
AU2003233733A1 (en) Compositions for cancer therapy saponins or sapogenins
AU2003255544A1 (en) Tumor specific oligosaccharide epitopes and use thereof
AU2003274963A1 (en) Mda-7 and free radicals in the treatment of cancer
AU2003291896A1 (en) Saponins and sapogenins for use in combination therapy for cancer
AU2003250831A1 (en) Use of hec1 antagonists in the treatment of proliferative disorders and cancer
AU2003230849A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU2003265023A1 (en) Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
AU2003219664A1 (en) Methods and therapeutic compositions in the treatment of advanced cancer
AU2003283339A1 (en) Cancer therapy determination

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase